Ardelyx reported $1.17M in Gross Profit on Sales for its third fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Gross Profit On Sales Change
TG Therapeutics TGTX:US 1.74M 341K
Abbott ABT:US $ 6505M 1225M
Amgen AMGN:US $ 5097M 208M
Ardelyx ARDX:US $ 1.17M 0.14M
Astrazeneca AZN:US 6.04B 15M
Biocept BIOC:US $ 7.18M 2.59M
Corcept Therapeutics CORT:US $ 94.86M 4.65M
Curis CRIS:US $ 2.89M 0.72M
Opko Health OPK:US $ 141.86M 7.64M
United Therapeutics UTHR:US $ 417M 7.7M